Fig. 1: Univariate analysis of potential risk factors in COVID-19 mortality.
From: CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Data are presented as ORs with 95% CI. ref, reference population. +BMI 18.5–24.9; ++BMI < 18.5; +++BMI > 25; #exposure to immunosuppressive medications not including cancer treatment; ^diagnosis or treatment within 6 months; *single-agent immunotherapy, targeted therapy or monoclonal antibodies.